These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19017358)

  • 1. Association of human NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injury.
    Reddy AJ; Christie JD; Aplenc R; Fuchs B; Lanken PN; Kleeberger SR
    J Cell Mol Med; 2009 Aug; 13(8B):1784-1791. PubMed ID: 19017358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
    Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
    Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T.
    Pan SS; Han Y; Farabaugh P; Xia H
    Pharmacogenetics; 2002 Aug; 12(6):479-88. PubMed ID: 12172217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
    Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
    Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer].
    Zhang WC; Yin LH; Pu YP; Liang GY; Hu X; Liu YZ; Cui YS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):324-7. PubMed ID: 17166422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel variants in the PRDX6 Gene and the risk of Acute Lung Injury following major trauma.
    Rushefski M; Aplenc R; Meyer N; Li M; Feng R; Lanken PN; Gallop R; Bellamy S; Localio AR; Feinstein SI; Fisher AB; Albelda SM; Christie JD
    BMC Med Genet; 2011 May; 12():77. PubMed ID: 21627785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
    Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
    J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.
    Nebert DW; Roe AL; Vandale SE; Bingham E; Oakley GG
    Genet Med; 2002; 4(2):62-70. PubMed ID: 11882782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of NAD(P)H quinone oxidoreductase (NQO1*2) polymorphism with NQO1 levels and risk of diabetic nephropathy.
    Sharma M; Mehndiratta M; Gupta S; Kalra OP; Shukla R; Gambhir JK
    Biol Chem; 2016 Aug; 397(8):725-30. PubMed ID: 27078674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
    Bock CH; Wenzlaff AS; Cote ML; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):381-6. PubMed ID: 15498787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of C609T-Inborn Polymorphism of NAD(P)H: Quinone Oxidoreductase 1 with the Risk of Bronchopulmonary Dysplasia in Preterm Neonates.
    Gavrili S; Zachaki S; Daraki A; Polycarpou E; Manola K; Stavropoulou C; Sambani C; Baroutis G
    Am J Perinatol; 2016 May; 33(6):535-9. PubMed ID: 26683602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis.
    Alexoudi A; Zachaki S; Stavropoulou C; Chatzi I; Koumbi D; Stavropoulou K; Kollia P; Karageorgiou CE; Sambani C
    Int J Neurosci; 2015 Jan; 125(1):32-7. PubMed ID: 24588223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
    Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
    Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
    Siegel D; McGuinness SM; Winski SL; Ross D
    Pharmacogenetics; 1999 Feb; 9(1):113-21. PubMed ID: 10208650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves.
    Chung JE; Chang BC; Lee KE; Kim JH; Gwak HS
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1229-36. PubMed ID: 26257249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease.
    Stavropoulou C; Zachaki S; Alexoudi A; Chatzi I; Georgakakos VN; Terzoudi GI; Pantelias GE; Karageorgiou CE; Sambani C
    Free Radic Biol Med; 2011 Aug; 51(3):713-8. PubMed ID: 21605663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
    Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
    Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Genetic Variations in NRF2, NQO1, HMOX1, and MT with Severity of Coronary Artery Disease and Related Risk Factors.
    Sarutipaiboon I; Settasatian N; Komanasin N; Kukongwiriyapan U; Sawanyawisuth K; Intharaphet P; Senthong V; Settasatian C
    Cardiovasc Toxicol; 2020 Apr; 20(2):176-189. PubMed ID: 31332605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.